ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO) announced today the launch of a new Morpheus^® SMART PICC bedside insertion kit and new 5 French Dual Lumen Peripherally Inserted Central Catheter (PICC) as part of the continued growth of its Morpheus SMART PICC line.

"These two launches represent our commitment to providing clinicians with a full portfolio of superior options within our Morpheus SMART PICC product line," said Shawn McCarthy, Senior Vice President and General Manager for AngioDynamics. "Through this, and other launches, we are continuing to build AngioDynamics' reputation as the destination for performance and broad choice."

The high performance Morpheus SMART PICC 5F Dual Lumen Smart PICC power-injectable catheter is designed to provide a superior flow rate of 5 mL/second for purposes of CT imaging. This performance upgrade complements AngioDynamics' advanced catheter shaft technology, which couples the pushability needed for PICC placement with pliability that minimizes the risk of vessel trauma and phlebitis. It also employs Smart Taper™ technology, which is designed to reduce the risk of thrombosis by allowing the catheter's diameter to quickly taper from seven French to a precise five French.

"Our facility conducts more than 3,500 PICC placements per year," said Julie Amicucci, Chief, Emergency Center Physician Extenders and Director of the PICC Team at William Beaumont Hospital, Royal Oak, Mich. "After switching to AngioDynamics, we've seen a reduced number of calls involving post procedure bleeding."

Ms. Amicucci said her facility also will experience benefits from the new Morpheus SMART PICC bedside insertion kit, which includes upgraded premium safety components — specifically, a new sharps container, upgraded safety scalpel, safety needles, larger absorbent drapes to protect the sterile field and two ChloraPrep® One-Step Applicators for maximum site preparation coverage. This new kit was designed to allow for safer, more efficient PICC placements at the patient's bedside.

"When travelling from bedside to bedside in a clinical setting, it is the little things that make the difference," Julie said. "The new AngioDynamics insertion kit is slimmer, which will allow us to store more kits per cart, and it has everything that is required for the procedure. This will allow us to provide better patient care by getting to patients faster, ultimately saving time and the hospital money."

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6609717&lang=en

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Greg Gin, 415-896-6820 (Investor Relations)
ggin@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com

Source: AngioDynamics, Inc.

News Provided by Acquire Media